menu close
clear_day clear_night Sign Up east Log In east
clear_day nightlight
search
menu close Sign Up east Log In east
Sign Up east Log In east
www.pivotbio.com

Pivot Bio Stock

Company Profile:

Pivot Bio is an agricultural technology company focused on delivering sustainable nitrogen solutions to enhance crop production. Founded to address the challenges of nitrogen delivery in farming, Pivot Bio aims to reduce the reliance on synthetic fertilizers while improving efficiency and sustainability in agriculture.

Sign up for SecondMarket™ to view the market and buy or sell Pivot Bio Stock
Buy + Sell

Pivot Bio Funding

Sign up to gain insights into Pivot Bio funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Jun 28, 2021 Series D 434.54M
Price
Valuation
Jan 06, 2020 Series C 100.00M
Price
Valuation
Oct 23, 2018 Series B 649.97K
Price
Valuation
Sep 13, 2018 Series B 70.68M
Price
Valuation
Mar 22, 2016 Series A 7.87M
Price
Valuation
Jan 13, 2016 Series A 8.12M
Price
Valuation
Oct 22, 2014 Series Seed 750.00K
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

See Pivot Bio Valuations + Financials

Sample data + company shown for illustrative purposes only

*Sample data + company shown for illustrative purposes only

Gain insights Into Pivot Bio Stock Valuation + Share Prices

View real-time Tape D™ data on Pivot Bio stock including most recent valuation and historical share price information.

Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.

Get Started
Leverage Your Equity to Help Achieve More.

Pivot Bio Management Team

  • Director

    Ryan Rakestraw

  • Director

    Christopher Abbott

  • Chief Information Officer

    John Walls

  • Director

    Cooper Rinzler

  • President, COO, Director

    Lisa Nunez Safarian

  • Director

    Matt Ocko

  • CEO, Co-Founder, Director

    Karsten Temme

  • Chief Scientific Officer, Co-Founder, Director

    Alvin Tamsir

  • Chief Financial Officer

    Douglas Jeffries

Pivot Bio Major Investors

  • DCVC

  • Rockefeller Capital Management

  • Breakthrough Energy Ventures (BEV)

  • Spruce Capital Partners

  • Generation Investment Management LLP

  • Temasek Holdings Pte, Ltd.

  • Temasek Holdings Pte, Ltd.

  • Monsanto Growth Ventures

  • Pavilion Capital

  • Prelude Ventures

  • Data Collective

  • Bunge Ventures

  • Codon Capital

  • Continental Grain Company

  • Tekfen Ventures

  • G2 Venture Partners

Learn More About Pivot Bio Stock

Buy Pivot Bio Stock
01
Pivot Bio stock does not trade on public stock exchanges. Pivot Bio stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in Pivot Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market. Get started to begin exploring private market opportunities.
Sell Pivot Bio Stock
02
Pivot Bio Stock does not trade on public stock exchanges. In order to sell Pivot Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors. Get started to begin exploring private market opportunities.
Pivot Bio Stock Price
03
Pivot Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Pivot Bio share price and other valuable private market data. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Pivot Bio Stock Ticker Symbol
04
There is no ticker symbol for Pivot Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Criteria to Sell Pivot Bio Stock
05
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Pivot Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Criteria to Buy or Invest in Pivot Bio Stock
06
Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in Pivot Bio stock you need to be an institutional investor. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Pivot Bio Stock Settlement
07
Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
Pivot Bio IPO
08
Pivot Bio is a private company and has not had an IPO. There is currently no Pivot Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Pivot Bio IPO.
Sign up for SecondMarket™ to view the market and buy or sell Pivot Bio Stock
Buy + Sell

Other Companies

Upside

Helps people get more value from their purchases and improves businesses' profitability while benefiting the world by offsetting carbon and food waste.

Industry Retail About Upside Stock →

Aledade

Primary care platform building Accountable Care Organizations (ACOs).

Industry Health Care About Aledade Stock →

Discord

Voice and text chat application for gamers that works on both desktop and phone.

Industry Entertainment Products + Services About Discord Stock →

Canva

Online design and publishing tool.

Industry Information Technology About Canva Stock →

Mercury

Bank accounts for tech companies.

Industry Banking + Payment About Mercury Stock →

Kallyope

The company is dedicated to unlocking the potential of the gut-brain axis using cutting-edge technologies for the development of therapeutics and products.

Industry Biotechnology + Pharmaceuticals About Kallyope Stock →
Source: Nasdaq Private Market Tape D™